Literature DB >> 9427307

Complement activation by cross-linked truncated and chimeric full-length beta-amyloid.

D H Cribbs1, P Velazquez, B Soreghan, C G Glabe, A J Tenner.   

Abstract

The activation of complement by beta-amyloid (A beta) has been implicated in the local inflammatory response in Alzheimer's disease. To assess the structural parameters required for this activation, beta-sheet-containing fibrils of A beta1-28 were induced by low pH and then chemically cross-linked to constrain the beta-sheet conformation. Chimeric A beta peptides with a substituted C-terminal sequence derived from two different transmembrane proteins were also assessed for the ability to form fibrils rich in beta-sheet structure and to activate complement. Both the cross-linked A beta1-28 and the chimeric A beta peptides were strong activators of the classical complement pathway. These results suggest that the C-terminal residues (29-42) of A beta facilitate fibril assembly required for complement activation but do not contain the interaction sites required for complement activation, further supporting the hypothesis that C1q binds to the N-terminal hydrophilic domain of A beta, and that a fibrillar beta-sheet-rich conformation is required for effective binding and activation of C1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427307     DOI: 10.1097/00001756-199711100-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  6 in total

1.  Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.

Authors:  Ming Li; Rahasson R Ager; Deborah A Fraser; Natalia O Tjokro; Andrea J Tenner
Journal:  Mol Immunol       Date:  2008-04-08       Impact factor: 4.407

2.  Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.

Authors:  S E Stoltzner; T J Grenfell; C Mori; K E Wisniewski; T M Wisniewski; D J Selkoe; C A Lemere
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules.

Authors:  Nicholas M Molino; Kateryna Bilotkach; Deborah A Fraser; Dongmei Ren; Szu-Wen Wang
Journal:  Biomacromolecules       Date:  2012-03-14       Impact factor: 6.988

Review 4.  Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.

Authors:  Andrea J Tenner
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 5.  Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk.

Authors:  Anastasia G Efthymiou; Alison M Goate
Journal:  Mol Neurodegener       Date:  2017-05-26       Impact factor: 14.195

6.  Asiaticoside ameliorates β-amyloid-induced learning and memory deficits in rats by inhibiting mitochondrial apoptosis and reducing inflammatory factors.

Authors:  Zhuo Zhang; Xiaobin Li; Duo Li; Mao Luo; Yongjie Li; Li Song; Xian Jiang
Journal:  Exp Ther Med       Date:  2016-12-27       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.